Chimin Health Management Co., Ltd.

Shanghai Stock Exchange 603222.SS

Chimin Health Management Co., Ltd. Revenue for the year ending December 31, 2023: USD 125.99 M

Chimin Health Management Co., Ltd. Revenue is USD 125.99 M for the year ending December 31, 2023, a 3.85% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Chimin Health Management Co., Ltd. Revenue for the year ending December 31, 2022 was USD 121.32 M, a -29.82% change year over year.
Chimin Health Management Co., Ltd. Revenue for the year ending December 31, 2021 was USD 172.88 M, a 28.58% change year over year.
Chimin Health Management Co., Ltd. Revenue for the year ending December 31, 2020 was USD 134.45 M, a 21.40% change year over year.
Chimin Health Management Co., Ltd. Revenue for the year ending December 31, 2019 was USD 110.76 M, a 9.16% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shanghai Stock Exchange: 603222.SS

Chimin Health Management Co., Ltd.

CEO	Mr. Yunfei Tian
IPO Date	Feb. 17, 2015
Location	China
Headquarters	No. 888, Beiyuan Road
Employees	1,947
Sector	Health Care
Industries Pharmaceuticals Medical Instruments

Description

Chimin Health Management Co., Ltd. develops, produces, and sells human drugs and medical devices in China. The company offers non-PVC soft bag double tube double valves, single valves, and single-tube double valves; plastic bottles; and other packaging forms. It also provides safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products; In Vitro diagnosis solutions; and hemodialysis supplies, as well as medical services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Huangyan, China.

Key trends

Past 5 years